Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
10,969 total articles
Eli Lilly remains the central beneficiary of the GLP-1 weight-loss boom. With orforglipron poised to expand oral market share, industry-leading margins, and near-$1 trillion market cap backing continuing cash generation, this is a structured long trade. Valuation is rich, so position sizing and a disciplined stop matter.
Lam Research is positioned to benefit from a multi-year wave of wafer fabrication equipment (WFE) spending driven by AI-capex and memory restocking. Recent beat-and-raise results, strong free cash flow and healthy balance-sheet metrics support a long bias. Valuation is rich today, but the supply-constrained nature of the cycle and durable margins g…
Talen Energy (TLN) is a leveraged, cash-flowing power generator whose recent acquisitions and exposure to wholesale power markets make it a direct beneficiary of higher natural gas and power prices. With regulatory clearance for new gas plants, stronger digital infrastructure demand, and a stretched but defendable balance sheet, TLN is a tradable l…
Oneok (OKE) offers a compelling mix of steady fee-based revenue, a near-5% yield, and valuation that still looks reasonable after recent gains. With multiple expansion projects coming online through 2028 and payout-backed free cash flow, a tactical long into $95 with a $79 stop captures both income and upside while keeping risk defined.
Nvidia's $2 billion strategic investment and a string of commercial wins turn Nebius from a regional builder into a global AI infrastructure play. Growth and capacity visibility justify a long trade into $112 with a measured stop and a $145 target over a 180-trading-day horizon, while risks around financing, valuation, and concentration warrant tig…
Reynolds Consumer Products (REYN) is trading near its 52-week low with an attractive yield, reasonable valuation (P/E ~15), and healthy free cash flow. Recent margin pressure and a CEO transition have pushed the stock lower, creating a tactical buying opportunity for a mid-term trade if you accept modest execution and commodity risks.
Micron likely faces an inflection after Q2 as inventory normalization and AI-driven demand for high-bandwidth memory converge. This trade idea lays out an entry at $95.00 with a stop at $75.00 and a primary target of $145.00 over a 180-trading-day horizon, with a nearer-term waypoint at $115.00 in 45 trading days.
Intuitive Surgical remains the leader in robotic-assisted surgery after another year of double-digit procedure growth and a growing installed base. The stock trades at a premium - ~61x earnings - but recent deceleration guidance creates a tactical entry opportunity. We recommend a long trade with an entry at $495, a stop at $460 and a target of $57…
JOYY (ADS) looks compelling after results that beat expectations and guidance that was raised. The stock is trading at a reasonable PE of 14.4, a low PB of 0.46 and a 6.3% dividend yield, while technicals and elevated short interest create a favorable setup for a swing trade.
Propel Holdings has reported its strongest growth cadence to date, yet the market remains cautious because of lingering profitability questions and conservative guidance. We lay out a mid-term trade: a tactical long with clear entry, stop, and target, plus the catalysts that could unlock upside and the risks that could pressure the name further.
Atmos Energy (ATO) is the largest natural-gas-only utility in the U.S., trading near $184 with a ~2% yield, a multi-decade dividend growth record, and regulated distribution economics. Valuation sits around 24x earnings and a $30.5B market cap — not cheap, but defensible given low leverage and stable demand. This trade idea outlines a long entry, s…
Hancock Whitney (HWC) looks tradeable here. At roughly $62.57 the stock offers a 2.9% yield, a P/E near 10.6, and free cash flow of about $572M. Technicals are oversold (RSI ~32) and short interest remains elevated, creating the conditions for a tactical long. This is not a conviction buy for a buy-and-forget portfolio — it is a disciplined, swing-…
Grifols (GRFS) combines a deep moat in plasma-derived therapies with a depressed valuation, a modest dividend, and a visibly oversold technical profile. I’m adding at $8.04 with a clear stop and target: the risk/reward looks asymmetric into a growing plasma market and a stable Biopharma franchise.
SolarEdge (SEDG) looks to be shifting from crisis to recovery. Fundamentals and technicals are aligning: revenue beats, positive free cash flow, price sitting above the 50-day moving average, and persistent short interest create a favorable asymmetric trade. This is a tactical long for traders willing to hold the name through near-term volatility.
Micron sits squarely in the AI memory supply chain with HBM demand tightening. Recent partnership headlines and guidance suggest revenue strength into Q2, yet multiples and sell-side caution imply some investors still underprice sustained HBM scarcity. This trade idea lays out a concrete long with entry at current levels, a disciplined stop and a $…
HCI Group (HCI) looks attractively valued on several fundamental metrics — EV/EBITDA ~3.8, free cash flow of $404M, and return on equity near 24% — with a $2.1B market cap and a corporate catalyst in the near term. Technicals are cautionary, but for investors willing to accept momentum risk, a structured buy with a disciplined stop offers a favorab…
PepsiCo (PEP) mixes low volatility with a reliable dividend, wide moat snack/beverage brands, and heavy liquidity. At $160.15, the stock trades near its 50-day average and offers a 3.5% dividend yield; that combination makes short-term option selling a compelling income strategy. This idea outlines a mid-term (45 trading days) covered-call plan (wi…
Lam Research has beaten recent estimates, guided higher, and sits squarely in the AI-driven capital expenditure cycle. Balance-sheet strength, robust free cash flow, and visible demand from memory and logic customers support a constructive long trade. Valuation is rich but not without justification given margins and cash generation; manage position…
Trupanion (TRUP) looks buyable after recent weakness. The stock trades near its 52-week low, valuation is reasonable relative to free cash flow, and recent industry recognition plus improving fundamentals create a clear risk-reward for a mid-term swing trade.
Progressive ($PGR) is experiencing a pause in top-line momentum, but underlying profitability and free cash generation remain robust. At ~$201, the stock trades near its 52-week low on an attractive ~11x earnings multiple and an EV/EBITDA around 9.1. This trade idea lays out a mid-term long with a clear entry, stop and target, while acknowledging c…
PepsiCo (PEP) has popped into early 2026 but still trades at a sensible multiple given its cash generation and dividend history. With a market cap near $219B, double-digit free cash flow and defensive demand, PEP is an actionable long with defined risk controls. The trade below targets upside toward the prior 52-week high while keeping a tight stop…
PepsiCo's pricing power, durable cash flow and an improving cost/mix backdrop support a tactical upgrade to long. The stock trades near $160 with a 3.5% yield, EV/EBITDA of 15.5 and FCF of $7.7B — valuations that leave room for upside as operating momentum normalizes. Trade plan provided for a mid-term swing (45 trading days).
LifeMD is cheaply priced for a telehealth platform that now offers GLP-1s (Wegovy/Ozempic) at competitive cash-pay rates, has positive free cash flow, and an enterprise value under $170M. With current technical momentum, a rising short interest profile, and clear distribution catalysts, a disciplined long with a $3.25 stop and $7.50 target offers a…
Hudson Technologies looks like an asymmetric opportunity: industrial cash-flow business, recent tuck-ins that expand recovered refrigerant supply, and valuation metrics (EV/EBITDA ~4.85, P/FCF ~5.58) that price in weakness. Technicals are oversold, creating a measured swing trade with a clear stop and a realistic target near prior highs.
Upstart is trading near its 52-week low despite improving technicals, a low RSI, and the prospect that a bank charter or similar deposit access could materially cut funding costs and lift margins. With a $2.67B market cap, negative free cash flow, and ongoing legal noise, this is a high-risk, high-reward swing trade: entry $27.00, stop $24.00, targ…
